GlassScriptPhysician profile
Jeevitha Patil
NPI 1598112575
$902.39
in general payments reported to CMS, 2019-2025
17 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $81.45 · 2023: $376 · 2024: $107 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $231.75 | 2021-2023 | |
| Organon LLC | $160.62 | 2023-2025 | Jada System, Nexplanon |
| Mayne Pharma Commercial LLC | $67.93 | 2022-2024 | |
| Hologic Sales and Service, LLC | $58.54 | 2022-2024 | Aptima |
| Becton, Dickinson and Company | $54.14 | 2025 | Arista |
| Aspira Women'S Health INC | $47.26 | 2023 | Ova1 |
| Exact Sciences Corporation | $40.42 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $37.87 | 2023-2024 | |
| Astellas Pharma US INC | $27.65 | 2023 | Veozah |
| Biogen, INC. | $26.17 | 2024 | Zurzuvae |
| Pfizer INC. | $25.71 | 2022 | |
| Shield Therapeutics INC | $23.76 | 2023 | Accrufer |
| Sumitomo Pharma America, INC. | $23.07 | 2023 | Myfembree |
| Exeltis, USA INC. | $21.48 | 2023 | Slynd |
| Coopersurgical, INC. | $19.40 | 2023 | Paragard T 380a |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $18.55 | 2023 | Balcoltra |
| Evofem Biosciences, INC. | $18.07 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeevitha Patil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.